ArticleViruses2022
Mapping and Validation of Peptides Differentially Recognized by Antibodies from the Serum of
Eneida Santos Oliveira, Naiara Clemente Tavares, Stella Garcia Colombarolli, Izabella Cristina Andrade Batista, Camila Sales Nascimento, Philip Louis Felgner, Rafael Ramiro de Assis, Carlos Eduardo Calzavara-Silva
Open access · goldAbstract read
In one paragraphArticle in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 86% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors at 4 institutions in 3 countries.
Eneida Santos OliveiraGerência da Rede Ambulatorial Especializada, Secretaria Municipal de Saúde de Belo Horizonte, Prefeitura de Belo Horizonte, 2336 Afonso Pena Avenue, Belo Horizonte 301300-007, Brazil.
Naiara Clemente TavaresGrupo de Imunologia Celular e Molecular, Instituto Rene Rachou, Fiocruz, 1715 Augusto de Lima Avenue, Belo Horizonte 30190-002, Brazil.
Stella Garcia ColombarolliGrupo de Imunologia Celular e Molecular, Instituto Rene Rachou, Fiocruz, 1715 Augusto de Lima Avenue, Belo Horizonte 30190-002, Brazil.ORCID 0000-0003-1526-2540 Izabella Cristina Andrade BatistaGrupo de Imunologia Celular e Molecular, Instituto Rene Rachou, Fiocruz, 1715 Augusto de Lima Avenue, Belo Horizonte 30190-002, Brazil.
Camila Sales NascimentoGrupo de Imunologia Celular e Molecular, Instituto Rene Rachou, Fiocruz, 1715 Augusto de Lima Avenue, Belo Horizonte 30190-002, Brazil.
Philip Louis FelgnerVaccine Research and Development Center, Department of Physiology, University of California, Irvine 3052 Hewitt Hall, Irvine, CA 92697, USA.
Rafael Ramiro de AssisVaccine Research and Development Center, Department of Physiology, University of California, Irvine 3052 Hewitt Hall, Irvine, CA 92697, USA.
Carlos Eduardo Calzavara-SilvaGrupo de Imunologia Celular e Molecular, Instituto Rene Rachou, Fiocruz, 1715 Augusto de Lima Avenue, Belo Horizonte 30190-002, Brazil.ORCID 0000-0002-1406-6401 Fundação Oswaldo Cruz · BRUniversity of California, Irvine · USNational Research Council · ITSecretaria Municipal de Saúde · BR
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Yellow Fever disease is caused by the
Indexed as
PeptidesYellow FeverYellow Fever VaccineAntibodiesHumansAntibodiesPeptidesYellow Fever Vaccinedifferential diagnosisflaviviruspeptide microarrayYellow Fever virus
Identifiers
PMID36016268
PMCPMC9415205
OpenAlexW4288725524
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390